Literature DB >> 21660066

Psychophysical impact and optical and morphological characteristics of symptomatic non-advanced cataract.

S Charalampidou1, J Nolan, J Loughman, J Stack, G Higgins, L Cassidy, S Beatty.   

Abstract

PURPOSE: To investigate whether psychophysical, morphological, and/or optical characteristics of symptomatic non-advanced cataract are complementary to, or more appropriate than, visual acuity (VA) for the purposes of recording visual data that reflect subjective visual difficulty in patients with cataract that exhibit relative sparing of high contrast acuity (0.4 logarithm of minimal angle of resolution (logMAR) scale or better).
METHODS: Eighty-two patients with symptomatic non-advanced cataract and no other ocular pathology were asked to complete a validated questionnaire, and to perform a series of visual function assessments including: corrected distance VA (CDVA); photopic and mesopic contrast sensitivity; photopic and mesopic glare disability (GD); reading acuity and reading speed; stereoacuity; and retinal sensitivity. Optical and morphological characteristics of the cataract were evaluated by lens optical density and by the Lens Opacities Classification System III, respectively. Correlations between questionnaire score and each of these measures were calculated.
RESULTS: Statistically significant negative correlations were observed between the Rasch-scaled questionnaire score and mesopic GD (at 3 and 6 cycles per degree (cpd); r=-0.396 (P<0.01) and -0.451 (P<0.05), respectively) and between the Rasch-scaled questionnaire score and photopic GD (at 3 and 6 cpd; r=-0.328 (P<0.01) and -0.440 (P<0.01), respectively).
CONCLUSION: Symptomatic non-advanced cataract, in the presence of good CDVA, is associated with measurable subjective visual difficulty, best reflected in a decrease in mesopic and photopic GD (at medium spatial frequencies). CDVA does not reflect the patient's visual dissatisfaction in such cases.

Entities:  

Mesh:

Year:  2011        PMID: 21660066      PMCID: PMC3178238          DOI: 10.1038/eye.2011.123

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  33 in total

1.  Reliability of a standardized reading chart system: variance component analysis, test-retest and inter-chart reliability.

Authors:  Eva Stifter; Franz König; Thomas Lang; Peter Bauer; Sibylla Richter-Müksch; Michaela Velikay-Parel; Wolfgang Radner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-10       Impact factor: 3.117

2.  The aging population and its impact on the surgery workforce.

Authors:  David A Etzioni; Jerome H Liu; Melinda A Maggard; Clifford Y Ko
Journal:  Ann Surg       Date:  2003-08       Impact factor: 12.969

3.  The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER.

Authors:  Aimee Teo Broman; Beatriz Munoz; Jorge Rodriguez; Rosario Sanchez; Harry A Quigley; Ronald Klein; Robert Snyder; Sheila K West
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-11       Impact factor: 4.799

4.  Contrast sensitivity predicts age-related differences in highway-sign discriminability.

Authors:  D W Evans; A P Ginsburg
Journal:  Hum Factors       Date:  1985-12       Impact factor: 2.888

5.  Contrast sensitivity predicts pilots' performance in aircraft simulators.

Authors:  A P Ginsburg; D W Evans; R Sekule; S A Harp
Journal:  Am J Optom Physiol Opt       Date:  1982-01

6.  Functional complaints, visual acuity, spatial contrast sensitivity, and glare disability in preoperative and postoperative cataract patients.

Authors:  R Superstein; D Boyaner; O Overbury
Journal:  J Cataract Refract Surg       Date:  1999-04       Impact factor: 3.351

7.  Prevalence of cataract and pseudophakia/aphakia among adults in the United States.

Authors:  Nathan Congdon; Johannes R Vingerling; Barbara E K Klein; Sheila West; David S Friedman; John Kempen; Benita O'Colmain; Suh-Yuh Wu; Hugh R Taylor
Journal:  Arch Ophthalmol       Date:  2004-04

8.  Five-year change in visual acuity following cataract surgery in an older community: the Blue Mountains Eye Study.

Authors:  J Panchapakesan; E Rochtchina; P Mitchell
Journal:  Eye (Lond)       Date:  2004-03       Impact factor: 3.775

9.  Functional vision with cataracts of different morphologies: comparative study.

Authors:  Eva Stifter; Stefan Sacu; Herbert Weghaupt
Journal:  J Cataract Refract Surg       Date:  2004-09       Impact factor: 3.351

Review 10.  Contrast sensitivity.

Authors:  Cynthia Owsley
Journal:  Ophthalmol Clin North Am       Date:  2003-06
View more
  6 in total

1.  Impact of cataract surgery on vision-related life performances: the usefulness of Real-Life Vision Test for cataract surgery outcomes evaluation.

Authors:  W Ni; X Li; Z Hou; H Zhang; W Qiu; W Wang
Journal:  Eye (Lond)       Date:  2015-08-14       Impact factor: 3.775

2.  Using the real-life vision test to assess the functional vision of age-related cataract patients.

Authors:  W Ni; X Li; M Ao; H Zhang; Z Hou; S Si; W Wang
Journal:  Eye (Lond)       Date:  2012-08-10       Impact factor: 3.775

3.  Visual Function and Its Relationship with Severity of Early, and Activity of Neovascular, Age-Related Macular Degeneration.

Authors:  James Loughman; Sarah Sabour-Pickett; John M Nolan; Barbara Klein; Ronald Klein; Stephen Beatty
Journal:  J Clin Exp Ophthalmol       Date:  2015-10-27

4.  Macular pigment and its contribution to vision.

Authors:  Ekaterina Loskutova; John Nolan; Alan Howard; Stephen Beatty
Journal:  Nutrients       Date:  2013-05-29       Impact factor: 5.717

5.  Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials.

Authors:  Kwadwo Owusu Akuffo; Stephen Beatty; Jim Stack; Jessica Dennison; Sarah O'Regan; Katherine A Meagher; Tunde Peto; John Nolan
Journal:  Ophthalmic Epidemiol       Date:  2014-04       Impact factor: 1.648

6.  Mesopic Disability Glare in Stage-Two Dysfunctional Lens Syndrome.

Authors:  Alfredo Holgueras; Manuel Marcos; Elena Martínez-Plaza; Alberto López-Miguel; Alberto Mansilla; Miguel J Maldonado
Journal:  Ophthalmol Ther       Date:  2022-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.